The Role of CONUT Score as a Prognostic Indicator in Progressive Pulmonary Fibrosis: An Accessible Tool for Clinical Risk Assessment - Summary - MDSpire
Advertisement
The Role of CONUT Score as a Prognostic Indicator in Progressive Pulmonary Fibrosis: An Accessible Tool for Clinical Risk Assessment
To evaluate the prognostic utility of the CONUT score in patients with progressive pulmonary fibrosis (PPF) and its significance in clinical risk assessment.
Key Findings:
The study included 58 patients, predominantly male (55.2%), with a high prevalence of comorbidities (93.2%).
Dyspnea and cough were the most common presenting symptoms.
F-HP was the most common subtype of PPF (48.2%).
CONUT score was found to be a significant prognostic indicator for PPF outcomes, with a p-value < 0.05.
Interpretation:
The CONUT score may serve as a practical and objective tool for assessing nutritional status and predicting outcomes in patients with PPF.
Limitations:
Retrospective design may introduce bias.
Limited sample size may affect generalizability.
Data collection relied on existing medical records, which may be incomplete.
Potential confounding factors were not controlled for in the analysis.
Conclusion:
The CONUT score is a promising prognostic tool for assessing risk in patients with progressive pulmonary fibrosis, warranting further validation in larger and more diverse cohorts.
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.
